656 resultados para benchmarking


Relevância:

20.00% 20.00%

Publicador:

Resumo:

Dissertação para obtenção do Grau de Mestre em Engenharia do Ambiente, Perfil de Gestão e Sistemas Ambientais

Relevância:

20.00% 20.00%

Publicador:

Resumo:

A Work Project, presented as part of the requirements for the Award of a Masters Degree in Economics from the NOVA – School of Business and Economics

Relevância:

20.00% 20.00%

Publicador:

Resumo:

O cimento é um produto essencial para a elaboração de infraestruturas e uma necessidade para o desenvolvimento económico. A sua produção implica elevados gastos energéticos que com o aumento do consumo, associado ao desenvolvimento da economia mundial, têm vindo a tornar os seus impactes cada vez mais significativos, incluindo outros aspectos ambientais como emissões e impactes na biodiversidade. A globalização fez com que cada vez mais organizações se esforçassem para superar a concorrência e adoptassem novas técnicas e tecnologias mais sustentáveis com recurso a indicadores de desempenho ambiental. A ausência de um documento sectorial de referência para o sector cimenteiro que defina critérios e indicadores de desempenho específicos do sector dificulta assim a tarefa de benchmarking de desempenho ambiental entre empresas do mesmo sector de actividade. A presente dissertação visa utilizar o benchmarking como ferramenta de gestão para avaliar o desempenho ambiental no sector cimenteiro. A avaliação é feita através de indicadores de desempenho elaborados com base nos dados disponíveis nas declarações ambientais das várias fábricas de cimento registadas no Sistema Comunitário de Eco-Gestão e Auditoria (EMAS) e procura estabelecer relações entre um elevado desempenho e as melhores prácticas, para identificação de melhoria potencial dos vários domínios relevantes da actividade das empresas do sector. Foi recolhida uma amostra composta por 23 fábricas de cimento na base de dados do EMAS, tendo sido efectuado um benchmarking entre 16 fábricas espanholas e portuguesas que constituem uma representatividade de 70 % do universo de organizações registadas. A fábrica que se apresentou mais vezes no top 3 de desempenho de cada indicador foi a fábrica da Secil-Outão, situação que se verificou em 6 dos 14 indicadores analisados. A fábrica da Lloseta e a de Cibra-Pataias estão presentes no top 3 de desempenho em 5 e 4 indicadores, respectivamente. De um modo geral, foram verificadas MTD’s implementadas e os níveis de desempenho nos vários indicadores são superiores aos valores definidos no Documento de Referência das Melhores Técnicas Disponíveis (BREF) de 2013, confirmando o empenho e compromisso das fábricas de cimento registadas no EMAS. Por fim, a metodologia desenvolvida foi aplicada no caso de estudo da Secil-Outão, tendo sido avaliado o desempenho da empresa nos diferentes indicadores e apresentando-se ainda uma análise das boas prácticas implementadas.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Dissertação de mestrado integrado em Engenharia e Gestão de Sistemas de Informação

Relevância:

20.00% 20.00%

Publicador:

Resumo:

We study a retail benchmarking approach to determine access prices for interconnected networks. Instead of considering fixed access charges as in the existing literature, we study access pricing rules that determine the access price that network i pays to network j as a linear function of the marginal costs and the retail prices set by both networks. In the case of competition in linear prices, we show that there is a unique linear rule that implements the Ramsey outcome as the unique equilibrium, independently of the underlying demand conditions. In the case of competition in two-part tariffs, we consider a class of access pricing rules, similar to the optimal one under linear prices but based on average retail prices. We show that firms choose the variable price equal to the marginal cost under this class of rules. Therefore, the regulator (or the competition authority) can choose one among the rules to pursue additional objectives such as consumer surplus, network covera.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Therapeutic drug monitoring (TDM) aims to optimize treatments by individualizing dosage regimens based on the measurement of blood concentrations. Dosage individualization to maintain concentrations within a target range requires pharmacokinetic and clinical capabilities. Bayesian calculations currently represent the gold standard TDM approach but require computation assistance. In recent decades computer programs have been developed to assist clinicians in this assignment. The aim of this survey was to assess and compare computer tools designed to support TDM clinical activities. The literature and the Internet were searched to identify software. All programs were tested on personal computers. Each program was scored against a standardized grid covering pharmacokinetic relevance, user friendliness, computing aspects, interfacing and storage. A weighting factor was applied to each criterion of the grid to account for its relative importance. To assess the robustness of the software, six representative clinical vignettes were processed through each of them. Altogether, 12 software tools were identified, tested and ranked, representing a comprehensive review of the available software. Numbers of drugs handled by the software vary widely (from two to 180), and eight programs offer users the possibility of adding new drug models based on population pharmacokinetic analyses. Bayesian computation to predict dosage adaptation from blood concentration (a posteriori adjustment) is performed by ten tools, while nine are also able to propose a priori dosage regimens, based only on individual patient covariates such as age, sex and bodyweight. Among those applying Bayesian calculation, MM-USC*PACK© uses the non-parametric approach. The top two programs emerging from this benchmark were MwPharm© and TCIWorks. Most other programs evaluated had good potential while being less sophisticated or less user friendly. Programs vary in complexity and might not fit all healthcare settings. Each software tool must therefore be regarded with respect to the individual needs of hospitals or clinicians. Programs should be easy and fast for routine activities, including for non-experienced users. Computer-assisted TDM is gaining growing interest and should further improve, especially in terms of information system interfacing, user friendliness, data storage capability and report generation.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

El objetivo específico del TFG es el de realizar un análisis riguroso en base a fuentes externas y referencias de probada veracidad en relación a la oferta universitaria actual de estudios de Grado de Informática y Telecomunicación en España en la modalidad de e-learning o educación a distancia.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

The aim of this study is to develop a model measuring the performance of cities' marketing efforts. The model and the benchmarking methodology presented can be used by local authorities to position their marketing efforts and achievements against other (competing) cities and to identify best practices that can assist place marketers in learning how to be more efficient obtaining desired place marketing results, e.g., improved city brand image, with the available resources/budgets. The major implication for practitioners is that place marketing should be managed as a process, taking into account both the resource flows and the outputs, as well as the efficiency of this process.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

In this paper we consider the equilibrium effects of an institutionalinvestor whose performance is benchmarked to an index. In a partialequilibrium setting, the objective of the institutional investor is modeledas the maximization of expected utility (an increasing and concave function,in order to accommodate risk aversion) of final wealth minus a benchmark.In equilibrium this optimal strategy gives rise to the two-beta CAPM inBrennan (1993): together with the market beta a new risk-factor (that wecall active management risk) is brought into the analysis. This new betais deffined as the normalized (to the benchmark's variance) covariancebetween the asset excess return and the excess return of the market overthe benchmark index. Different to Brennan, the empirical test supports themodel's predictions. The cross-section return on the active management riskis positive and signifficant especially after 1990, when institutionalinvestors have become the representative agent of the market.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

We study a retail benchmarking approach to determine access prices for interconnected networks. Instead of considering fixed access charges as in the existing literature, we study access pricing rules that determine the access price that network i pays to network j as a linear function of the marginal costs and the retail prices set by both networks. In the case of competition in linear prices, we show that there is a unique linear rule that implements the Ramsey outcome as the unique equilibrium, independently of the underlying demand conditions. In the case of competition in two-part tariffs, we consider a class of access pricing rules, similar to the optimal one under linear prices but based on average retail prices. We show that firms choose the variable price equal to the marginal cost under this class of rules. Therefore, the regulator (or the competition authority) can choose one among the rules to pursue additional objectives such as consumer surplus, network coverage or investment: for instance, we show that both static and dynamic e±ciency can be achieved at the same time.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

We use best practice benchmarking rationales to propose a dynamic research design that accounts for the endogenous components of across-firms heterogeneous routines to study changes in performance and their link to organizational knowledge investments. We thus contribute to the operationalization of management theoretical frameworks based on resources and routines. The research design employs frontier measures that provide industry-level benchmarking in organizational settings, and proposes some new indicators for firm-level strategic benchmarking. A profit-oriented analysis of the U.S. technology industry during 2000-2011 illustrates the usefulness of our design. Findings reveal that industry revival following economic distress comes along with wider gaps between best and worst performers. Second stage analyses show that increasing intangibles stocks is positively associated with fixed target benchmarking, while enhancing R&D spending is linked to local frontier progress. The discussion develops managerial interpretations of the benchmarking measures that are suitable for control mechanisms and reward systems.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Se introduce la necesidad de evaluar y comparar el desarrollo del e-gobierno y se analizan los instrumentos existentes. En primer lugar se presentan los modelos de evolución del e-gobierno actualmente en uso y se discuten sus características y utilidad. Un análisis de los estudios comparativos muestra el interés que despierta el área de administración electrónica. Seguidamente se analizan los estudios comparativos más relevantes sobre provisión electrónica de servicios públicos en la administración local. Ambos análisis ponen de manifiesto las limitaciones de los estudios existentes en su aplicabilidad en el ámbito local. Algunas son: la escasez de trabajos sobre administración local, la medida de la adopción de los servicios públicos, y el uso de modelos de evolución de e-gobierno que no reflejan las nuevas tendencias en prestación de servicios. Finalmente se señalan mejoras a realizar en futuras evaluaciones comparativas de servicios electrónicos para incrementar su aplicabilidad en la administración local.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Introduction: Therapeutic drug monitoring (TDM) aims at optimizing treatment by individualizing dosage regimen based on measurement of blood concentrations. Maintaining concentrations within a target range requires pharmacokinetic and clinical capabilities. Bayesian calculation represents a gold standard in TDM approach but requires computing assistance. In the last decades computer programs have been developed to assist clinicians in this assignment. The aim of this benchmarking was to assess and compare computer tools designed to support TDM clinical activities.¦Method: Literature and Internet search was performed to identify software. All programs were tested on common personal computer. Each program was scored against a standardized grid covering pharmacokinetic relevance, user-friendliness, computing aspects, interfacing, and storage. A weighting factor was applied to each criterion of the grid to consider its relative importance. To assess the robustness of the software, six representative clinical vignettes were also processed through all of them.¦Results: 12 software tools were identified, tested and ranked. It represents a comprehensive review of the available software's characteristics. Numbers of drugs handled vary widely and 8 programs offer the ability to the user to add its own drug model. 10 computer programs are able to compute Bayesian dosage adaptation based on a blood concentration (a posteriori adjustment) while 9 are also able to suggest a priori dosage regimen (prior to any blood concentration measurement), based on individual patient covariates, such as age, gender, weight. Among those applying Bayesian analysis, one uses the non-parametric approach. The top 2 software emerging from this benchmark are MwPharm and TCIWorks. Other programs evaluated have also a good potential but are less sophisticated (e.g. in terms of storage or report generation) or less user-friendly.¦Conclusion: Whereas 2 integrated programs are at the top of the ranked listed, such complex tools would possibly not fit all institutions, and each software tool must be regarded with respect to individual needs of hospitals or clinicians. Interest in computing tool to support therapeutic monitoring is still growing. Although developers put efforts into it the last years, there is still room for improvement, especially in terms of institutional information system interfacing, user-friendliness, capacity of data storage and report generation.